NCT01061840View on ClinicalTrials.gov

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 6, 2018

Study Completion Date

January 31, 2019

Conditions
Ewings SarcomaNon Small Cell Lung CancerLiver Cancer
Interventions
BIOLOGICAL

Vigil™

Patients will be treated once a month as long as sufficient material is available for up to 12 doses

BIOLOGICAL

Vigil™

Patients will be treated once a month as long as sufficient material is available for up to 12 doses

BIOLOGICAL

Vigil™

Patients will be treated once a month as long as sufficient material is available for up to 12 doses

Trial Locations (4)

33401

Florida Cancer Specialists, West Palm Beach

75230

Mary Crowley Cancer Research Centers, Dallas

99202

Cancer Care Northwest, Spokane

03756

Dartmouth-Hitchcock Medical Center/ Norris Cotton Cancer Center, Lebanon

Sponsors

Lead Sponsor

Gradalis, Inc.
All Listed Sponsors
lead

Gradalis, Inc.

INDUSTRY